Next Article in Journal
(Benzoylamino)methyl 4-Hydroxybenzoate
Previous Article in Journal
Manganese 5,10,15,20-Tetra(N-ethyl-3-carbazolyl) Porphyrin
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Note

5-Methyl-4-oxo-4,6-dihydro-3H-pyridazino[4,5-b]carbazole-1-carbonitrile

Department of Drug and Natural Product Synthesis, Faculty of Life Sciences, University of Vienna, Althanstraße 14, A-1090 Vienna, Austria
*
Author to whom correspondence should be addressed.
Molbank 2010, 2010(1), M657; https://doi.org/10.3390/M657
Submission received: 15 January 2010 / Accepted: 1 February 2010 / Published: 3 February 2010

Abstract

:
The title compound was prepared in excellent yield from 5-methyl-4-oxo-4,6-dihydro-3H-pyridazino[4,5-b]carbazole-1-carbaldehyde by treatment with hydroxylamine hydrochloride in formic acid without isolation of the intermediate oxime.

In a recent communication [1], we reported the synthesis of 5-methyl-4-oxo-4,6-dihydro-3H-pyridazino[4,5-b]carbazole-1-carbaldehyde (1) by oxidation of the corresponding hydroxymethyl precursor [2] with a hypervalent iodine reagent. Such functionalised tetracyclic pyridazines are of interest as aza analogues of the pyrido[4,3-b]carbazole alkaloids, ellipticine and olivacine [3,4,5] and related antitumor agents. The synthesis and anticancer activity of polycyclic nitrogen heterocycles of this and other types has been a major subject in our department’s recent research activities [6,7,8,9,10,11].
In order to extend our library of pyridazino[4,5-b]carbazole derivatives, the aldehyde 1 was chosen for further functionalisation at position 1 of the tetracyclic system. Whereas the aldehyde functionality, in principle, offers a wide variety of derivatisation options, the very low solubility of such fused pyridazinones in common organic solvents represents a challenge with respect to compound handling, work-up, and purification. Transformation into a carbonitrile was envisaged, as it would furnish a stable carboxylic acid derivative offering high flexibility with respect to further derivatisation. Initial attempts to effect the desired transformation of the aldehyde into the nitrile via the corresponding oxime in two consecutive steps gave unsatisfactory results. However, we found that the target nitrile (2) can be prepared very efficiently by treatment of the aldehyde with hydroxylamine hydrochloride in refluxing formic acid in the presence of a catalytic amount of concentrated sulfuric acid, applying a one-pot protocol previously reported by Bertini et al. [12]. The product, in this case, can be isolated very conveniently by dilution of the reaction mixture with water, followed by filtration of the precipitate. The structure of compound 2 thus obtained in 95% yield is clearly evident from its spectral data. The IR spectrum shows a nitrile absorption band at 2,240 cm-1. In the 1H NMR spectrum, the aldehydic proton is no longer detectable and in the 13C NMR spectrum the aldehyde carbon signal (at 191.9 ppm) had disappeared in favour of a resonance at 114.7 ppm, which is typical for the nitrile carbon atom.
Molbank 2010 m657 i001

Experimental

The melting point was determined on a Kofler hot-stage microscope (Reichert) and is uncorrected. The IR spectrum was recorded on a Perkin-Elmer Spectrum 1000 instrument, 1H NMR and 13C NMR spectra were recorded on a Varian UnityPlus 300 spectrometer. The low-resolution mass spectrum was obtained on a Shimadzu QP5050A DI 50 instrument, the HR-MS was recorded on a Finnigan MAT 8230 at the Institute of Organic Chemistry, University of Vienna.

5-Methyl-4-oxo-4,6-dihydro-3H-pyridazino[4,5-b]carbazole-1-carbonitrile (2)

To a suspension of 5-methyl-4-oxo-4,6-dihydro-3H-pyridazino[4,5-b]carbazole-1-carbaldehyde (1) [1] (100 mg, 0.37 mmol) in formic acid (2 mL) was added hydroxylamine hydrochloride (149 mg, 0.55 mmol) and one drop of concentrated sulfuric acid. The mixture was refluxed for 16 h, then it was cooled to room temperature and diluted with water (6 mL). The precipitate was collected by filtration, washed with water, and dried to afford the nitrile 2 as brownish crystals, m.p. > 300 °C (decomp.); yield: 97 mg (95%).
IR (KBr): 3362, 3171, 2240, 1648, 1501, 1376, 1265, 1235, 1107, 750 cm-1.
MS (EI, 70 eV): m/z = 275 (19%), 274 (M+, 100), 218 (18), 217 (12), 216 (11), 191 (21), 82 (11).
1H NMR (DMSO-d6, 300 MHz): δ = 3.15 (3H, s, 5-CH3), 7.29–7.35 (1H, m, 9-H), 7.57–7.67 (2H, m, 7-H, 8-H), 8.48 (1H, d, J = 8.1 Hz, 10-H), 8.58 (1H, s, 11-H), 12.02 (1H, s, carbazole-NH), 12.99 (1H, s, pyridazinone-NH).
13C NMR (DMSO-d6, 75 MHz): δ = 15.1 (5-CH3), 111.6, 113.9, 114.7 (nitrile-C), 120.0, 120.6, 120.8, 121.4, 121.9, 122.2, 123.9, 126.4, 128.5, 141.6, 141.8, 160.8 (4-C).
HR-MS Calcd. for C16H10N4O: 274.0855. Found: 274.0851.

Supplementary materials

Supplementary File 1Supplementary File 2Supplementary File 3

Acknowledgements

We are grateful to Ing. P. Unteregger for recording the high-resolution mass spectrum.

References and Notes

  1. Emich, M.; Haider, N. 5-Methyl-4-oxo-4,6-dihydro-3H-pyridazino[4,5-b]carbazole-1-carbaldehyde. Molbank 2009, 2009, M623. [Google Scholar] [CrossRef]
  2. Haider, N.; Sotelo, E. 1,5-Dimethyl-6H-pyridazino[4,5-b]carbazole, a 3-aza bioisoster of the antitumor alkaloid olivacine. Chem. Pharm. Bull. 2002, 50, 1479–1483. [Google Scholar] [CrossRef] [PubMed]
  3. Gribble, G.W. Synthesis and antitumor activity of ellipticine alkaloids and related compounds. In The Alkaloids; Brossi, A., Ed.; Academic Press: New York, NY, USA, 1990; pp. 239–352. [Google Scholar]
  4. Ohashi, M.; Oki, T. Ellipticine and related anticancer agents. Exp. Opin. Ther. Patents 1996, 6, 1285–1294. [Google Scholar] [CrossRef]
  5. Haider, N. Diazine analogues of the pyridocarbazole alkaloids. Curr. Org. Chem. 2006, 10, 363–375. [Google Scholar] [CrossRef]
  6. Haider, N. Pyridazine-fused carbazoles: Synthesis, reactivity, and antitumor activity. J. Heterocycl. Chem. 2002, 39, 511–521. [Google Scholar] [CrossRef]
  7. Haider, N.; Kabicher, T.; Käferböck, J.; Plenk, A. Synthesis and in vitro antitumor activity of 1-[3-(indol-1-yl)prop-1-yn-1-yl]phthalazines and related compounds. Molecules 2007, 12, 1900–1909. [Google Scholar] [CrossRef] [PubMed]
  8. Haider, N.; Jbara, R.; Käferböck, J.; Traar, U. Synthesis of tetra- and pentacyclic carbazole-fused imides as potential antitumor agents. Arkivoc 2009, 38–47. [Google Scholar]
  9. Pongprom, N.; Mueller, G.; Schmidt, P.; Holzer, W.; Spreitzer, H. Carbinol derivatives of azanaphthoquinone annelated pyrrols. Monatsh. Chem. 2009, 140, 309–313. [Google Scholar] [CrossRef]
  10. Shanab, K.; Pongprom, N.; Wulz, E.; Holzer, W.; Spreitzer, H.; Schmidt, P.; Aicher, B.; Mueller, G.; Günther, E. Synthesis and biological evaluation of novel cytotoxic azanaphthoquinone annelated pyrrolo oximes. Bioorg. Med. Chem. Lett. 2007, 17, 6091–6095. [Google Scholar] [CrossRef] [PubMed]
  11. Spreitzer, H.; Puschmann, C. Dual function antitumor agents based on bioreduction and DNA alkylation. Monatsh. Chem. 2007, 138, 517–522. [Google Scholar] [CrossRef]
  12. Bertini, V.; Lucchesini, F.; Pocci, M.; De Munno, A. 3,5-Dichloro-4-pyridinecarbonitrile as a key reagent in a synthesis of copper containing amine oxidase inhibitors. Heterocycles 1995, 41, 675–688. [Google Scholar] [CrossRef]

Share and Cite

MDPI and ACS Style

Emich, M.; Haider, N. 5-Methyl-4-oxo-4,6-dihydro-3H-pyridazino[4,5-b]carbazole-1-carbonitrile. Molbank 2010, 2010, M657. https://doi.org/10.3390/M657

AMA Style

Emich M, Haider N. 5-Methyl-4-oxo-4,6-dihydro-3H-pyridazino[4,5-b]carbazole-1-carbonitrile. Molbank. 2010; 2010(1):M657. https://doi.org/10.3390/M657

Chicago/Turabian Style

Emich, Miriam, and Norbert Haider. 2010. "5-Methyl-4-oxo-4,6-dihydro-3H-pyridazino[4,5-b]carbazole-1-carbonitrile" Molbank 2010, no. 1: M657. https://doi.org/10.3390/M657

APA Style

Emich, M., & Haider, N. (2010). 5-Methyl-4-oxo-4,6-dihydro-3H-pyridazino[4,5-b]carbazole-1-carbonitrile. Molbank, 2010(1), M657. https://doi.org/10.3390/M657

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop